These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 23085043

  • 1. A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice.
    Bagai U, Pawar A.
    Parasitol Int; 2013 Jun; 62(3):329-36. PubMed ID: 23085043
    [Abstract] [Full Text] [Related]

  • 2. Infection with Plasmodium berghei boosts antibody responses primed by a DNA vaccine encoding gametocyte antigen Pbs48/45.
    Haddad D, Maciel J, Kumar N.
    Infect Immun; 2006 Apr; 74(4):2043-51. PubMed ID: 16552033
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Murine immune responses to liver-stage antigen 1 protein FMP011, a malaria vaccine candidate, delivered with adjuvant AS01B or AS02A.
    Brando C, Ware LA, Freyberger H, Kathcart A, Barbosa A, Cayphas S, Demoitie MA, Mettens P, Heppner DG, Lanar DE.
    Infect Immun; 2007 Feb; 75(2):838-45. PubMed ID: 17101665
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS, Mukherjee P, Yazdani SS, Shakri AR, Mazumdar S, Pandey S, Chitnis CE, Chauhan VS.
    Vaccine; 2007 Jul 09; 25(28):5166-74. PubMed ID: 17544179
    [Abstract] [Full Text] [Related]

  • 11. 43 kDa and 66 kDa, two blood stage antigens induce immune response in Plasmodium berghei malaria.
    Pirta C, Banyal HS.
    Indian J Exp Biol; 2014 Aug 09; 52(8):781-6. PubMed ID: 25141540
    [Abstract] [Full Text] [Related]

  • 12. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
    Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, Gao G, Ertl HC, Wilson JC, Hill AV.
    Eur J Immunol; 2008 Mar 09; 38(3):732-41. PubMed ID: 18266272
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.
    Mauduit M, Grüner AC, Tewari R, Depinay N, Kayibanda M, Chavatte JM, Franetich JF, Crisanti A, Mazier D, Snounou G, Rénia L.
    PLoS One; 2009 Nov 05; 4(11):e7717. PubMed ID: 19890387
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum.
    Teo WH, Nurul AA, Norazmi MN.
    Trop Biomed; 2012 Jun 05; 29(2):239-53. PubMed ID: 22735846
    [Abstract] [Full Text] [Related]

  • 18. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice.
    Lv Y, Wu S, Nie Q, Liu S, Xu W, Chen G, Du Y, Chen J.
    Int Immunopharmacol; 2024 May 10; 132():111982. PubMed ID: 38569430
    [Abstract] [Full Text] [Related]

  • 19. The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.
    Goodman AL, Forbes EK, Williams AR, Douglas AD, de Cassan SC, Bauza K, Biswas S, Dicks MD, Llewellyn D, Moore AC, Janse CJ, Franke-Fayard BM, Gilbert SC, Hill AV, Pleass RJ, Draper SJ.
    Sci Rep; 2013 May 10; 3():1706. PubMed ID: 23609325
    [Abstract] [Full Text] [Related]

  • 20. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V, Romero JF, Kensil C, Corradin G.
    Vaccine; 2005 Apr 15; 23(21):2801-12. PubMed ID: 15780728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.